Full notification fileGeneral informationNotification NumberB/NL/15/011Member State to which the notification was sentNetherlandsDate of acknowledgement from the Member State Competent Authority23/11/2015Title of the ProjectVaccination of chickens with a herpes virus of turkey vaccine with inserted the F-gene of Newcastle Disease Virus and the VP2 gene of Infectious Bursal Disease Virus.Proposed period of release:01/01/2016 to 31/12/2018Name of the Institute(s) or Company(ies)Intervet International bv, Boxmeer, The Netherlands;
3. Is the same GMO release planned elsewhere in the Community?NoHas the same GMO been notified elsewhere by the same notifier?NoGMO characterizationGMO is a:DNA VirusIdentity of the GMO:The Innovax-ND-IBD vaccine contains the live cell-associated Herpesvirus of Turkey (HVT) strain HVP360 in a cell-associated form. This is a vector vaccine: the HVP360 virus strain was generated by inserting the F-gene of Newcastle Disease Virus (NDV) and the VP2 gene of Infectious Bursal Disease Virus (IBDV) into the HVT strain FC-126 genome.
HVT belongs to the virus family Herpesviridae, subfamily Alphaherpesvirinae, genus "Marek's disease-like viruses" (also known as the genus Mardivirus).Information relating to the recipient or parental organisms from wich the GMO is derived
European Commission administrative informationConsent given by the Member State Competent Authority:Not known
|HVT||Mardivirus||Meleagrid herpesvirus 1||-||FC-126||-|